Trium Capital’s Globus Medical GMED Stock Holding History

Trium Capital’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3	Closed	–	–	72
2023 Q3	$0	Buy	+3	New	+$168	﹤0.01%	81

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Trium Capital's GMED Position: Q4 2023 in Review

Trium Capital sold out of Globus Medical (GMED) in Q4 2023, closing a stake of 3 shares.

Trium Capital first reported a position in GMED in Q3 2023 and held it in 1 quarter. The position peaked at $0 in Q3 2023. 408 funds tracked by Wall St. Rank hold GMED as of Q4 2023.

Trium Capital reported no remaining Globus Medical position as of Q4 2023 after selling out during the quarter.
Trium Capital sold 3 Globus Medical shares in Q4 2023.
Trium Capital first reported a position in Globus Medical in Q3 2023 and held it in 1 quarter.
Trium Capital's Globus Medical position peaked at $0 in Q3 2023.
408 funds tracked by Wall St. Rank held Globus Medical as of Q4 2023.

Based on Trium Capital's 13F filing for Q4 2023, filed 9 Feb 2024.